Cargando…
Uveal Melanoma Metastatic to the Liver: The Role of Quantitative Volumetric Contrast-Enhanced MR Imaging in the Assessment of Early Tumor Response after Transarterial Chemoembolization()
PURPOSE: To determine whether volumetric changes of enhancement as seen on contrast-enhanced magnetic resonance (MR) imaging can help assess early tumor response and predict survival in patients with metastatic uveal melanoma after one session of transarterial chemoembolization (TACE). MATERIALS AND...
Autores principales: | Duran, Rafael, Chapiro, Julius, Frangakis, Constantine, Lin, MingDe, Schlachter, Todd R., Schernthaner, Rüdiger E., Wang, Zhijun, Savic, Lynn J., Tacher, Vania, Kamel, Ihab R., Geschwind, Jean-François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202794/ https://www.ncbi.nlm.nih.gov/pubmed/24953419 http://dx.doi.org/10.1016/j.tranon.2014.05.004 |
Ejemplares similares
-
A new angiographic imaging platform reduces radiation exposure for patients with liver cancer treated with transarterial chemoembolization
por: Schernthaner, Ruediger E., et al.
Publicado: (2015) -
Longitudinal Analysis of the Effect of Repeated Transarterial Chemoembolization for Liver Cancer on Portal Venous Pressure
por: Frangakis, Constantine, et al.
Publicado: (2021) -
Theranostic application of lipiodol for transarterial chemoembolization in a VX2 rabbit liver tumor model
por: van Breugel, Johanna Maria Mijntje, et al.
Publicado: (2019) -
Automated feature quantification of Lipiodol as imaging biomarker to predict therapeutic efficacy of conventional transarterial chemoembolization of liver cancer
por: Stark, Sophie, et al.
Publicado: (2020) -
Lipiodol as an Imaging Biomarker of Tumor Response After Conventional Transarterial Chemoembolization: Prospective Clinical Validation in Patients with Primary and Secondary Liver Cancer
por: Miszczuk, Milena A., et al.
Publicado: (2020)